A novel antiviral may soon become available to treat dengue infections, which impacts millions of people and is threatening people in south Florida and Puerto Rico in 2023.
While two dengue vaccines are authorized in certain countries, no antiviral is commercially available.
Dengue Antiviral Candidate Found Efficacious and Safe
Age, Cancer Type Affect COVID-19 Vaccine Uptake in Cancer Patients
Higher rates of vaccination seen in older patients; lower rates seen for metastatic solid tumors, with comorbidities
COVID-19-Related Stress During Pregnancy Tied to Poor Postpartum Outcomes
COVID-19-related stress associated with maternal mental health and infant negative affectivity
COVID-19-Related Financial Disruptions Linked to Child Mental Health
No association seen for school disruptions with mental health, including stress, sadness, COVID-19-related worry